UCSF Benioff Children's Hospital Antimicrobial Susceptibility: Pseudomonas aeruginosa

The table below details the percent susceptibility of inpatient isolates of Pseudomonas aeruginosa to single agents and to the combination of antimicrobials indicated (number to the right of the arrow).  Excludes isolates from patients with cystic fibrosis.  Data are from 2016-2018.

 MER=meropenem; TOB=tobramycin; PIPTAZ=piperacillin/tazobactam; CFPM=cefepime; CIP=ciprofloxacin

 Population

Number of Isolates

PIPTAZ -->

PIPTAZ + CIP

PIPTAZ -->

PIPTAZ + TOB

CFPM -->

CFPM + CIP

CFPM -->

CFPM + TOB

MER  -->

MER + CIP

MER -->

MER + TOB

All inpatient/ED isolates

133

84%--> 97%

84% --> 100%

92% --> 97%

92% --> 100%

91% --> 99%

91% --> 100%

ICU*

62

82% --> 97%

82% --> 100%

92% --> 97%

92% --> 100%

92% --> 98%

92% --> 100%

non-ICU

71

86% --> 97%

86% --> 100%

91% --> 97%

91% --> 100%

90% --> 100%

90% --> 100%

* ICU = combined ICN, PICU and CICU - 12 isolates from ICN, remainder from PICU, PCICU